Not applicableUnknownNCT06227416What this trial is testingSkin Tumor Biomarkers by Mass Spectrometry ImagingWho this might be right forSkin CancerSquamous Cell CarcinomaBasal Cell Carcinoma+1 more Bispebjerg Hospital 300
Large-scale testing (Phase 3)Temporarily pausedNCT05050162What this trial is testingComparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck CancerWho this might be right forAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hypopharyngeal Squamous Cell CarcinomaAdvanced Laryngeal Squamous Cell Carcinoma+7 more NRG Oncology 1,714
Early research (Phase 1)Looking for participantsNCT04429542What this trial is testingStudy of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell CarcinomaSquamous Cell Carcinoma of Anal CanalColorectal Cancer+8 more Bicara Therapeutics 292
Not applicableStudy completedNCT04540588What this trial is testingRetreatment With Intratumoral Diffusing Alpha Radiation EmittersWho this might be right forSkin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm Alpha Tau Medical LTD. 2
Testing effectiveness (Phase 2)UnknownNCT01129154What this trial is testingPanitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)Who this might be right forCarcinoma, Squamous Cell Cliniques universitaires Saint-Luc- Université Catholique de Louvain 17
Testing effectiveness (Phase 2)Study completedNCT00369512What this trial is testingA Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell CarcinomaWho this might be right forCancer University of Alabama at Birmingham 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Early research (Phase 1)Study completedNCT04670679What this trial is testingA Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors Erasca, Inc. 90
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT00240682What this trial is testingStudy of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFRWho this might be right forSkin DiseasesCarcinoma, Squamous Cell Centre Hospitalier of Chartres 37
Large-scale testing (Phase 3)Looking for participantsNCT05381597What this trial is testing5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin CancerWho this might be right forSuperficial Basal Cell CarcinomaSquamous Cell Carcinoma in Situ Boston University 200
Early research (Phase 1)Active Not RecruitingNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Testing effectiveness (Phase 2)Ended earlyNCT02452424What this trial is testingA Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more Daiichi Sankyo 78
Not applicableEnrolling By InvitationNCT06885424What this trial is testingA Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) ProductsWho this might be right forSolid Tumor CancerSolid Tumor, Unspecified, AdultColorectal Carcinoma+12 more A2 Biotherapeutics Inc. 400
Early research (Phase 1)Study completedNCT03236935What this trial is testingPhase Ib of L-NMMA and PembrolizumabWho this might be right forNon-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more The Methodist Hospital Research Institute 12
Early research (Phase 1)Study completedNCT01727076What this trial is testingRecombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerWho this might be right forHead and Neck Squamous Cell CarcinomaRecurrent Head and Neck CarcinomaRecurrent Non-Small Cell Lung Carcinoma+11 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134What this trial is testingStudy of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerWho this might be right forCancerTumor, SolidAdvanced Solid Tumor+19 more Salubris Biotherapeutics Inc 263
Early research (Phase 1)Study completedNCT04160065What this trial is testingImmunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin CancersWho this might be right forMerkel Cell CarcinomaCutaneous Squamous Cell CarcinomaNon-Melanoma Skin Cancers TuHURA Biosciences, Inc. 23
Testing effectiveness (Phase 2)Looking for participantsNCT04895709What this trial is testingBMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsWho this might be right forCervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more Bristol-Myers Squibb 1,109
Testing effectiveness (Phase 2)UnknownNCT05229614What this trial is testingImmunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable DiseaseWho this might be right forNon Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMelanoma+1 more CNAO National Center of Oncological Hadrontherapy 27